| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.10B | +7.9% |
| Cost of Revenue | $3.17B | +10.0% |
| Gross Profit | $7.93B | +7.1% |
| R&D Expense | $1.64B | +11.0% |
| SG&A Expense | $1.20B | +31.1% |
| Operating Income | $2.28B | -1.8% |
| Pre-tax Income | $2.31B | +1.3% |
| Income Tax | $311.0M | +4.7% |
| Net Income | $2.03B |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.87B | -23.3% |
| Accounts Receivable | $135.0M | +25.0% |
| Current Assets | $5.09B | -32.8% |
| Total Assets | $17.61B | -9.1% |
| Current Liabilities | $4.64B | -24.0% |
| Long-term Debt | $6.00B | +4.2% |
| Total Liabilities | $12.99B | -8.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.96B | -18.8% |
| Capital Expenditures | $525.0M | +14.6% |
| Investing Cash Flow | $1.42B | -35.8% |
| Financing Cash Flow | -$3.66B | +3.8% |
| Free Cash Flow | $1.43B | -26.7% |
| +2.8% |
| EPS (Basic) | $4.43 | +11.0% |
| EPS (Diluted) | $4.34 | +10.2% |
| Stockholders' Equity |
| $4.62B |
| -10.5% |